Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,788.00    28.00 (0.74%)
Bid:
3,782.00
Ask:
3,794.00
Spread: 12.00 (0.317%)
Market Cap: £1.06b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

7 Nov 2012 07:00

RNS Number : 4869Q
4imprint Group PLC
07 November 2012
 



 

 

4imprint Group plc 7 November 2012

Interim Management Statement

The Board of 4imprint Group plc, the international promotional products Group, today issues its interim management statement for the period from 1 July 2012 to 6 November 2012, incorporating information relating to the financial performance of the business for its third quarter, being the period from 1 July 2012 to 29 September 2012.

The Group continues to report strong organic revenue growth. Third quarter group revenue, from continuing operations, was £47.86m, 14% ahead of prior year. Year to date revenue (39 weeks ended 29 September 2012) was £136.21m, 15% ahead of prior year. Overall the year to date growth is consistent with the Board's expectations.

4imprint Direct Marketing (92% of Group revenue)

Revenue for the third quarter was £44.47m, 14% ahead of prior year. Year to date revenue was £125.77m, 16% ahead of prior year.

Third quarter North American revenue was US$67.57m, 12% ahead of prior year. Year to date revenue was US$190.37m, 14% ahead of prior year.

In North America, in the third quarter, the number of orders received increased by 15% and 37,000 new customers were acquired. Total number of orders received year to date was 17% ahead of prior year. The year to date average order value was 2% below prior year, a reflection of caution in the current uncertain political and economic environment. Revenue for October has continued the positive momentum.

UK Direct Marketing revenue was 14% ahead of prior year in both the third quarter and year to date.

SPS (8% of Group revenue)

Third quarter total revenue in SPS was £3.78m, 6% ahead of prior year and year to date total revenue, at £11.58m, was 8% ahead of prior year. Order intake remains positive with the benefit of new products and enhanced marketing activity.  

Cash

The Group retains a strong financial position following the sale of Brand Addition and continued cash generation by the core business.

In the third quarter a property was purchased, in Manchester, for the UK Direct Marketing business, which needs to vacate the Brand Addition office which it occupies. The cost of the building and fit out is expected to be £0.95m and it is due to be in use before the year end.

 Outlook

Results to date indicate that, subject to macroeconomic conditions, the Group is on track for a good performance for the year.

 

John Poulter, Chairman of 4imprint, commenting on the IMS said:

"The Group is continuing to report strong organic revenue growth. Supported by a robust financial position, we continue to be well placed to take advantage of the growth opportunities presented by 4imprint Direct Marketing's large and highly fragmented US market. The Group continues to explore opportunities to reduce the legacy pension scheme risks."

 

 

 

For further information please contact:

4imprint Group plc

Tel: + 44 (0) 20 7299 7201

MHP Communications

 

 

John Poulter

Chairman

 

Gillian Davies

Group Finance Director

Reg Hoare

Tel: + 44 (0) 20 3128 8793

 

Katie Hunt

Tel: + 44 (0) 20 3128 8794

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBLGGBGDL
Date   Source Headline
11th Apr 20134:39 pmRNSDirector Declaration
12th Mar 20131:20 pmRNSHolding(s) in Company
12th Mar 201310:53 amRNSHolding(s) in Company
12th Mar 201310:18 amRNSDirector/PDMR Shareholding
8th Mar 20134:43 pmRNSHolding(s) in Company
8th Mar 20132:34 pmRNSHolding(s) in Company
8th Mar 20132:33 pmRNSHolding(s) in Company
5th Mar 20137:00 amRNSFinal Results
28th Feb 20139:36 amRNSTotal Voting Rights
6th Feb 20135:42 pmRNSBlock Listing Six Monthly Return
5th Feb 201310:02 amRNSHolding(s) in Company
23rd Jan 20137:00 amRNSTrading update and Notice of final results
17th Jan 20132:19 pmRNSApplication for Blocklisting
11th Jan 20139:34 amRNSHolding(s) in Company
10th Jan 20132:16 pmRNSAppointment of joint corporate broker
3rd Jan 201312:52 pmRNSDirector/PDMR Shareholding
14th Dec 201210:41 amRNSHolding(s) in Company
29th Nov 201210:34 amRNSHolding(s) in Company
26th Nov 20125:45 pmRNSEBT purchase
23rd Nov 201210:12 amRNSPension Buy-in
7th Nov 20127:00 amRNSInterim Management Statement
5th Nov 20121:26 pmRNSHolding(s) in Company
18th Oct 201211:01 amRNSNotice of Interim Management Statement
2nd Oct 201210:03 amRNSHolding(s) in Company
2nd Oct 20129:38 amRNSEBT Purchase
18th Sep 201211:21 amRNSHolding(s) in Company
10th Sep 201210:55 amRNSHolding(s) in Company
6th Sep 20123:40 pmRNSEBT Share Purchase
28th Aug 20121:28 pmRNSDirector/PDMR Shareholding
24th Aug 201210:18 amRNSDirector/PDMR Shareholding
23rd Aug 20127:00 amRNSDirector/PDMR Shareholding
2nd Aug 20127:00 amRNSHalf Yearly Report
28th Jun 20129:37 amRNSNotice of Results
26th Jun 20124:51 pmRNSHolding(s) in Company
25th Jun 201212:07 pmRNSHolding(s) in Company
11th Jun 20127:00 amRNSBoard Changes
11th May 20128:40 amRNSHolding(s) in Company
4th May 201212:13 pmRNSResult of AGM
3rd May 201211:00 amRNSInterim Management Statement
30th Apr 20124:28 pmRNSHolding(s) in Company
16th Apr 20123:22 pmRNSAnnual Information Update
16th Apr 201210:22 amRNSHolding(s) in Company
3rd Apr 20124:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20124:35 pmRNSPrice Monitoring Extension
29th Mar 20124:43 pmRNSAnnual Financial Report
23rd Mar 201212:23 pmRNSCompletion of the Sale of Brand Addition
21st Mar 20124:32 pmRNSHolding(s) in Company
19th Mar 20127:00 amRNSDirector/PDMR Shareholding
14th Mar 20123:18 pmRNSResult of Meeting
12th Mar 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.